Ticker Scorecard - BNGO Basics Company: Bionano Genomics, Inc. IPO Date: September 21, 2018 Sector: Healthcare Industry: Diagnostics and Research Market Cap: $20.64M Activated in VL: True Average Daily Range Avg Daily Range: $0.12 | 4.58% Avg Daily Range (30 D): $0.02 | 7.73% Avg Daily Range (90 D): $0.02 | 5.62% Institutional Daily Volume Avg Daily Volume: 1.36M Avg Daily Volume (30 D): 9.57M Avg Daily Volume (90 D): 4.78M Trade Size Avg Trade Size (Sh.): 56 Avg Trade Size (Sh.) (30 D): 860 Avg Trade Size (Sh.) (90 D): 698 Institutional Trades Total Inst.Trades: 870 Avg Inst. Trade: $1.76M Avg Inst. Trade (30 D): $.7M Avg Inst. Trade (90 D): $.7M Avg Inst. Trade Volume: .03M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.59M Avg Closing Trade (30 D): $.7M Avg Closing Trade (90 D): $.7M Avg Closing Volume: 58.81K     News Jan 3, 2025 @ 7:34 PM Bionano Announces $10 Million Registered Direct Of... Source: N/A Dec 31, 2024 @ 8:26 PM Bionano Announces Amendment to Senior Secured Conv... Source: Bionano Genomics, Inc. Oct 10, 2024 @ 12:00 PM Bionano Announces Preliminary 3Q 2024 Revenues and... Source: N/A Jul 17, 2024 @ 5:35 PM 10 Consumer Discretionary Stocks With Whale Alerts... Source: Benzinga Insights, Benzinga Staff Writer May 8, 2024 @ 10:30 PM Bionano Genomics (BNGO) Q1 2024 Earnings Call Tran... Source: newsfeedback@fool.com (Motley Fool Transcribing) Financials   TTM Q2 2024 Q1 2024 Basic EPS $-5.02 $-.24 $-.6 Diluted EPS $-5.02 $-.24 $-.6 Revenue $ 36.58M $ 7.77M $ 8.77M Gross Profit $ 10.6M $ 2.59M $ 2.82M Net Income / Loss $ -204.1M $ -16.22M $ -31.42M Operating Income / Loss $ -186.31M $ -17.02M $ -31.12M Cost of Revenue $ 25.98M $ 5.19M $ 5.95M Net Cash Flow $ 6.58M $ 5.67M $ -2.19M PE Ratio     Splits Aug 07, 2023:   10:1